Calidi Biotherapeutics CLDI
NYSE CLDI
$1.33 -0.03 (-2.21%)
As of: Sep 10, 2026 · 12:24 PM EDT

Calidi Biotherapeutics (CLDI) EPS (Diluted) (2022 - 2026)

Analysis

Calidi Biotherapeutics (CLDI) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.79
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn - -0.94
3 Iovance Biotherapeutics 3.66 Bn 3.36 Bn 55.72 Mn -0.11
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 0.42
5 uniQure 3.02 Bn 3.02 Bn 5.49 Mn -1.22
6 Beam Therapeutics 2.54 Bn 2.54 Bn - -1.18
7 Precigen 2.38 Bn 2.38 Bn 52.17 Mn 0.05
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn -0.05
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 0.04
10 Calidi Biotherapeutics 1.88 Mn -2.22 Mn - -2.94
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.94
Dec 31, 2025 -15.09
Sep 30, 2025 -35.29
Jun 30, 2025 -31.78
Mar 31, 2025 -35.34
Dec 31, 2024 -98.27
Sep 30, 2024 -124.03
Jun 30, 2024 -268.05
Mar 31, 2024 -390.22
Dec 31, 2023 -935.65
Sep 30, 2023 -271.57
Jun 30, 2023 -1,214.99
Mar 31, 2023 -628.05
Dec 31, 2022 -842.59
Sep 30, 2022 -495.65
Jun 30, 2022 347.38
Mar 31, 2022 122.06